Tag: GMET

  • NASDAQ New Lows: The Medicines Company (NASDAQ:MDCO), LipoScience (NASDAQ:LPDX), GeoMet (OTCMKTS:GMET), KiOR (NASDAQ:KIOR)

    Levi & Korsinsky, LLP Notifies Investors of Class Action against The Medicines Company (NASDAQ:MDCO) and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014. The Medicines Company (NASDAQ:MDCO) shares after opening at $28.66 moved to $29.31 on last trade day and at the end of the day closed at $27.90. Company price to sales ratio in past twelve months was calculated as 2.49 and price to cash ratio as 3.57. The Medicines Company (NASDAQ:MDCO) showed a negative weekly performance of -5.17%.

    Raleigh diagnostics company LipoScience, Inc. (NASDAQ:LPDX) terminated its relationship with Health Diagnostics Laboratory, Inc., one of its laboratory customers, after HDL began offering its own version of roughly the same test LipoScience manufactures. LipoScience Inc. (NASDAQ:LPDX) shares fell -19.63% in last trading session and ended the day on $3.03. LPDX return on equity ratio is recorded as -33.80% and its return on assets is -14.40%. LipoScience Inc. (NASDAQ:LPDX) yearly performance is -71.17%.

    GeoMet, Inc. (OTCMKTS:GMET) announced that its Board of Directors has declared a quarterly dividend to its preferred stockholders covering the period January 1, 2014 through March 31, 2014 to be paid through the issuance of .03125 preferred share per outstanding share of preferred stock. GeoMet Inc. (OTCMKTS:GMET) shares moved down -13.93% in last trading session and was closed at $0.0105, while trading in range of $0.01 – $0.01. GeoMet Inc. (OTCMKTS:GMET) year to date (YTD) performance is -89.50%.

    On March 26, 2014, Fred Cannon, the President and Chief Executive Officer of KiOR, Inc. (NASDAQ:KIOR), notified the Company of his resignation as President, effective immediately. Mr. Cannon will continue to serve as the Company’s Chief Executive Officer and principal executive officer. KiOR Inc. (NASDAQ:KIOR) weekly performance is -38.81%. On last trading day company shares ended up $0.410. KiOR Inc. (NASDAQ:KIOR) distance from 50-day simple moving average (SMA50) is -64.93%. Analysts mean target price for the company is $2.15.